microRNA Deal Struck

by Chris on February 25, 2010

Regulus Therapeutics and GlaxoSmithKline Establish New Collaboration to …
MarketWatch (press release)‎
Regulus Therapeutics Inc. today announced the establishment of a new collaboration with GlaxoSmithKline (GSK) to develop and commercialize microRNA …

Market Report — In Play (GSK)
MSN Money
GlaxoSmithKline and Regulus Therapeutics establish new collaboration to develop and commercialize microRNA Therapeutics Targeting miR-122 Co and Regulus …

Regulus, the MicroRNA Child of Isis and Alnylam, Strikes Potential $150M Deal …
Xconomy
Two years have passed since GlaxoSmithKline anointed a startup called Regulus Therapeutics as a leader in the bleeding-edge world of microRNA drugs, …

Related posts:

  1. Largest microRNA Therapeutics Alliance To Date
  2. Targeting a Master Regulator of Disease
  3. RXi Pharmaceuticals and miRagen Therapeutics Announce Formation of Research Collaboration in the Field of microRNA
  4. A Busy Month in the Business of microRNA
  5. Alnylam Pharmaceuticals & Regulus Therapeutics in the News

Leave a Comment

Previous post:

Next post: